- Home
- CCSI vs CGEM Comparison
CCSI vs CGEM Comparison
Compare CCSI & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- CGEM
- Stock Information
- Founded
- CCSI 2021
- CGEM 2016
- Country
- CCSI United States
- CGEM United States
- Employees
- CCSI N/A
- CGEM N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- CCSI Technology
- CGEM Health Care
- Exchange
- CCSI Nasdaq
- CGEM Nasdaq
- Market Cap
- CCSI 475.1M
- CGEM 490.3M
- IPO Year
- CCSI N/A
- CGEM 2021
- Fundamental
- Price
- CCSI $23.20
- CGEM $7.62
- Analyst Decision
- CCSI Hold
- CGEM Strong Buy
- Analyst Count
- CCSI 5
- CGEM 4
- Target Price
- CCSI $27.20
- CGEM $32.00
- AVG Volume (30 Days)
- CCSI 146.8K
- CGEM 502.1K
- Earning Date
- CCSI 05-07-2025
- CGEM 05-08-2025
- Dividend Yield
- CCSI N/A
- CGEM N/A
- EPS Growth
- CCSI N/A
- CGEM N/A
- EPS
- CCSI 4.32
- CGEM N/A
- Revenue
- CCSI $349,374,000.00
- CGEM N/A
- Revenue This Year
- CCSI $1.26
- CGEM N/A
- Revenue Next Year
- CCSI $0.88
- CGEM N/A
- P/E Ratio
- CCSI $5.43
- CGEM N/A
- Revenue Growth
- CCSI N/A
- CGEM N/A
- 52 Week Low
- CCSI $12.67
- CGEM $6.85
- 52 Week High
- CCSI $32.10
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- CCSI 65.46
- CGEM 43.88
- Support Level
- CCSI $19.24
- CGEM $7.50
- Resistance Level
- CCSI $24.03
- CGEM $8.13
- Average True Range (ATR)
- CCSI 0.98
- CGEM 0.48
- MACD
- CCSI 0.55
- CGEM -0.04
- Stochastic Oscillator
- CCSI 83.74
- CGEM 8.16
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.